General Information of the Compound
| Compound ID |
CP0410217
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C36H40N4O3S
|
||||||||||||||||||
| Molecular Weight |
608.808
|
||||||||||||||||||
| Canonical SMILES |
Cn1c(SCC(=O)[C@@]2(O)CC[C@H]3[C@@H]4CCC5=Cc6c(C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)cnn6-c2ccccc2)nc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H40N4O3S/c1-34-18-22-20-37-40(24-9-5-4-6-10-24)29(22)17-23(34)13-14-25-26-15-16-36(43,35(26,2)19-30(41)32(25)34)31(42)21-44-33-38-27-11-7-8-12-28(27)39(33)3/h4-12,17,20,25-26,30,32,41,43H,13-16,18-19,21H2,1-3H3/t25-,26-,30-,32+,34-,35-,36-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GDPBRHOXHFXBSK-BVNXUOMESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT00870, Glucocorticoid receptor